Transient inhibition of LIMKs significantly attenuated central sensitization and delayed the development of chronic

Xiangyu Yang1, Guiqin He1, Xiaoyun Zhang1

  • 1Institute of Life Sciences, The Key Laboratory of Developmental Genes and Human Disease, Southeast University, Nanjing 210096, China.

Neuropharmacology
|July 4, 2017
PubMed

Insights

Targeting LIM-domain kinases (LIMKs) during their activation phase can alleviate chronic pain. LIMK deficiency impaired pain development, and inhibition reduced central sensitization and pain behaviors.

Area of Science:

  • Neuroscience
  • Pain Research
  • Molecular Biology

Background:

  • Central sensitization is a key mechanism in chronic pain, a condition with limited treatment options.
  • LIM-domain kinases (LIMKs) regulate neural activities like synaptogenesis and gene expression, impacting synaptic plasticity and memory.
  • Understanding LIMK's role in pain pathways is crucial for developing novel pain therapies.

Purpose of the Study:

  • To investigate the role of LIM-domain kinases (LIMKs) in the development and maintenance of chronic pain.
  • To explore the potential of targeting LIMKs as a therapeutic strategy for chronic pain conditions.
  • To elucidate the specific mechanisms by which LIMKs contribute to central sensitization.

Main Methods:

  • Utilized a spared nerve injury (SNI) model to study chronic pain mechanisms.
  • Assessed the impact of LIMK deficiency on pain behaviors and central sensitization.
  • Employed pharmacological inhibition of LIMKs during specific activation phases.

Main Results:

  • LIMK deficiency significantly impaired the development of various chronic pain forms.
  • LIMKs play a pivotal role in up-regulating synaptic transmission and synaptogenesis post-pain induction.
  • Pharmacological inhibition of LIMKs during their activation phase effectively reduced central sensitization and pain behaviors.

Conclusions:

  • LIMKs are critical mediators of central sensitization and chronic pain development.
  • Selective targeting of LIMKs during their activation phase offers a promising therapeutic strategy for chronic pain.
  • This approach may be particularly effective for chronic pain with predictable onset, such as post-surgical pain (PSP).

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.4K
Local Anesthetics: Mechanism of Action01:23

Local Anesthetics: Mechanism of Action

Local anesthetics (LAs) block sensory and motor impulses by inhibiting the sodium channels on the nerve cell membranes. This induces temporary loss of sensation, relieving pain in a specific body area.
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
3.6K
Long-term Potentiation01:35

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
59.0K
Long-term Potentiation01:25

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
3.7K
Local Anesthetics: Differential Sensitivity of Nerve Fibers01:24

Local Anesthetics: Differential Sensitivity of Nerve Fibers

Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
1.5K
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
33.5K